1839P Circulating tumor DNA (ctDNA) low pass whole genome sequencing (lpWGS) studies identify genomic alterations associating with taxane outcomes in prospective phase III taxane trials for metastatic castration resistant prostate cancer (mCRPC) sufferers
Autor: | Seed, G., Greening, S., Goodall, J., Rekowski, J., Christova, R., Mehra, N., Eisenberger, M., Fizazi, K., Tombal, B., Wülfing, C., Sternberg, C.N., Castellano Gauna, D.E., Oudard, S., Sartor, O., Geffriaud-Ricouard, C., Chadjaa, M., Mace, S., Carreira, S., Yuan, W., de Bono, J.S. |
---|---|
Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S996-S997 |
Databáze: | ScienceDirect |
Externí odkaz: |